NEW BRUNSWICK, N.J. , March 17, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 14 th to review first-quarter results. Joseph J. Wolk , Executive Vice President, Chief Financial Officer and Christopher
Research well underway as Janssen scientists collaborate with leading virology laboratory led by Dan Barouch, M.D., Ph.D. NEW BRUNSWICK, N.J. , March 13, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Janssen Pharmaceutical Companies have entered a collaboration with
NEW BRUNSWICK, N.J. , Feb. 26, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Barclays Global Healthcare Conference on Wednesday, March 11 th , at the Loews Miami Beach Hotel , Miami Beach , FL. Ciro Romer , Company Group Chairman, Medical Devices North America will
Janssen strengthens collaboration with Biomedical Advanced Research and Development Authority (BARDA) in an effort to stem the threat of the global COVID-19 outbreak NEW BRUNSWICK, N.J. , Feb. 18, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Janssen Pharmaceutical
NEW BRUNSWICK, N.J. , Feb. 12, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 9 th Annual SVB Leerink Global Healthcare Conference on Wednesday, Feb. 26 th , at Lotte New York Palace, NY. Ashley McEvoy , Executive Vice President, Worldwide Chairman, Medical Devices will
Janssen joins forces with Biomedical Advanced Research and Development Authority (BARDA) to protect communities against threat of a global COVID-19 pandemic NEW BRUNSWICK, N.J. , Feb. 11, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Janssen Pharmaceutical Companies
